Gary Kobinger, PhD, is the Director of the Galveston National Laboratory, one of the largest active biocontainment facilities on an academic campus.

Dr. Kobinger has co-authored over 300 peer-reviewed scientific manuscripts and accumulated more than 20 years of experience working in or managing high- containment laboratories. His research presently focuses on developing and testing new vaccine platforms and immune treatments against pathogens of high consequences to global public health.

Serving the international community, Dr. Kobinger sits on several committees including the Scientific advisory committee of the Institut Pasteur de Dakar, Senegal.